SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016736
Filing Date
2021-12-14
Accepted
2021-12-14 06:35:20
Documents
14
Period of Report
2021-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20211214x8k.htm   iXBRL 8-K 35313
2 EX-99.1 gbio-20211214xex99d1.htm EX-99.1 20603
3 GRAPHIC gbio-20211214xex99d1001.jpg GRAPHIC 5418
  Complete submission text file 0001558370-21-016736.txt   186834

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20211214.xsd EX-101.SCH 2823
5 EX-101.LAB gbio-20211214_lab.xml EX-101.LAB 13141
6 EX-101.PRE gbio-20211214_pre.xml EX-101.PRE 11159
7 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20211214x8k_htm.xml XML 4905
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 211489635
SIC: 2834 Pharmaceutical Preparations